Jennifer Linge
CSO AMRA Medical
Seminars
Wednesday 15th April 2026
Reshaping the Standard: MRI Body Composition for Treatment Evaluation and Differentiation
11:00 am
- A new standard for muscle and fat quantification has been introduced through FDA-cleared MRI-based body composition analysis, enabling translation from population studies and clinical trials all the way into healthcare
- Studies on weight and BMI-invariant personalized z-scores for muscle and fat show improved prediction of outcomes and how potential targeted treatment effects independent of weight reduction can be described
- Changes in muscle composition (quantity and quality), and shifts in fat distribution during weight reduction can be understood by exploring normative data and recent clinical trials evaluating obesity treatments
